Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof

Inactive Publication Date: 2004-09-30
TECHNION RES & DEV FOUND LTD
View PDF0 Cites 120 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, satisfactory methods of diagnosing, characterizing, and treating many kinds of pathogen-associated diseases such as diseases associated with lymphotropic viruses such as IIIV or HTLV are unavailable.
However, all of the aforementioned prior art approaches suffer from significant disadvantages: (i) approaches involving the use TCRs or portions thereof as compounds capable of specifically binding particular MHC / peptide complexes are suboptimal due to the relatively low intrinsic binding affinity of TCRs for such complexes; (ii) approaches involving the use of antibodies or portions thereof specific for MHC / peptide complexes comprising non-human MHC are not suitable for human application; and (iii) approaches involving antibodies or portions thereof specific for MHC / non-pathogen derived antigen complexes are not suitable for specifically binding complexes comprising pathogen derived antigens.
Thus, all prior art approaches have failed to provide an adequate solution for providing molecules capable of specifically binding with high specificity and affinity a particular human APM / pathogen-derived antigen complex.
However, all such prior art approaches suffer from significant drawbacks.
Prior art approaches involving molecules capable of specifically binding complexes comprising non-human APMs do not have utility for human applications, and prior art approaches involving compositions-of-matter capable of specifically binding complexes comprising non-pathogen derived antigens do not have utility for applications requiring molecules capable of specifically binding complexes comprising pathogen-derived antigens, such as diagnosis, characterization, and treatment of pathogen infections in humans.
Thus, the prior art has failed to provide molecules capable of binding particular human APM / pathogen-derived antigen complexes with optimal specificity and affinity.
Furthermore, such immune responses may be pathogenic to the individual, for example by triggering harmful inflammatory reactions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
  • Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
  • Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0369] Generation of Reagents Capable of Binding with Optimal Affinity and Specificity Particular Human APM / Pathogen-Derived Antigen Complexes Applicatle Towards Optimal Diagnosis, Characterization, and Treatment of Human Pathogen Infections

[0370] Diseases associated with a pathogen infection, such as a viral infection, include numerous debilitating or lethal diseases of major medical and economic impact, including influenza, the common cold, and acquired immunodeficiency syndrome (AIDS). One theoretically potent approach which has been proposed for diagnosing, characterizing, and treating such pathogen mediated diseases involves using compounds capable of binding specific human antigen-presenting molecule (APM) / pathogen-derived peptide complexes. Such compounds could be used to identify and characterize pathogen infected cells / tissues, or APCs exposed to viral antigens with optimal specificity, to deliver cytotoxic agents with optimal selectivity and efficiency to pathogen infected...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Compositionaaaaaaaaaa
Biological propertiesaaaaaaaaaa
Affinityaaaaaaaaaa
Login to View More

Abstract

A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen is disclosed.

Description

FIELD AND BACKGROUND OF THE INVENTION[0001] The present invention relates to compositions-of-matter capable of specifically binding particular antigen-presenting molecule (APM) / antigen complexes. More particularly, the present invention relates to compositions-of-matter capable of specifically binding a particular human APM / pathogen-derived antigen complex.[0002] Diseases caused by pathogens, such as viruses, mycoplasmas, bacteria, fungi, and protozoans, account for a vast number of diseases, including highly debilitating / lethal diseases, affecting all human individuals at numerous instances during their lifetime. For example, diseases caused by retroviruses are associated with various immunological, neurological, and neoplastic disorders. For example, diseases caused by lymphotropic retroviruses, such as acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV), or the closely related human T-cell lymphotropic virus (HTLV), a causative agent of various ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/00C07K16/22
CPCA61K2039/505C07K16/22A61K39/21C07K16/00A61K39/0005C07K2317/73A61K39/00A61P31/04A61P31/10A61P31/12A61P31/18A61P33/02C07K16/28
Inventor REITER, YORAMCOHEN, CYRIL
Owner TECHNION RES & DEV FOUND LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products